Midnight is the deadline—your free gift is valued at $159. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| Ends tonight at 11:59 p.m. MDT! |
|
|
|
|
| Don’t miss your chance to get a free Owlet Cam 2 ($159 value) when you purchase FDA-cleared Dream Sock! |
|
|
|
|
| Be Part of the Owlet Family |
|
| Trusted by over 1 million parents, Owlet is a leader in infant health data. Our award-winning technology is designed to give you the sleep you need and the peace of mind you deserve. |
|
|
|
|
| Offer available only in the U.S. at owletcare.com from 01/18/2025 - 01/20/2025 or while supplies last. See Terms & Conditions. Not all products qualify for payment via FSA/HSA. Subject to eligibility. Payment options through Affirm are provided by these lending partners: affirm.com/lenders. |
|
|
|
|
BabySat® and full-featured FDA-cleared Dream Sock® experience available in the U.S. only. FDA-cleared Dream Sock features for healthy babies between ages 1-18 months and weighing 6-30 lbs is available through an Owlet Dream App update, at no additional cost. Dream Sock is intended to track babies' pulse rate and oxygen level and keep parents informed. BabySat is a prescription-only device intended for babies 1-18 months and 6-30 lbs that could benefit from additional monitoring at home, under the supervision of a physician. Dream Sock and BabySat are not intended to diagnose, treat or cure any disease or other condition, including but not limited to, Sudden Infant Death Syndrome (SIDS), Brief Resolved Unexplained Event (BRUE), and/or Respiratory Syncytial Virus (RSV). Medical decisions should never be made solely using Dream Duo and Dream Sock data. BabySat, Dream Duo and Dream Sock should not substitute for the care and oversight of an adult or consultation with medical professionals.
|
|
|
|
|
